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doi:10.1Objective: There are few data on whether prior fundoplication has an impact on subsequent esophageal resection
and reconstruction. The aim of this study is to review our experience with patients undergoing esophagectomy
after previous fundoplication.
Methods:Medical records were reviewed of all patients undergoing esophageal resection from 1988 to 2008 at
the Mayo Clinic. Patients with a fundoplication before esophagectomy were compared with a matched control
group who had esophagectomy alone.
Results: There were 2313 esophageal resections, and 80 patients had undergone at least 1 previous anti-reflux
surgery. Indications for esophagectomy were benign stricture/perforation in 41 patients, cancer in 28 patients,
and dysplasia in 11 patients. The surgical approach was Ivor Lewis in 38 patients, left thoracoabdominal in 29
patients, transhiatal in 10 patients, and McKeown in 3 patients. The conduit used was stomach in 70 patients,
jejunum in 6 patients, and colon in 3 patients; 1 patient had a diversion and cervical esophagostomy only. Oper-
ative mortality occurred in 3 patients (3.7%). Postoperative complications occurred in 50 patients (62.5%),
including anastomotic leak in 17 (21.5%). Sixteen patients (20%) required reoperation for complications.
Complication, anastomotic leak, and reoperation rates were significantly higher in patients with anti-reflux
surgery before esophagectomy compared with matched controls.
Conclusion: Esophagectomy after prior anti-reflux surgery is challenging, but the stomach is usually a suitable
conduit for esophageal replacement. Patients with a history of anti-reflux surgery who undergo esophagectomy
are at significantly increased risk for postoperative complications, anastomotic leak, and need for reoperation.
(J Thorac Cardiovasc Surg 2010;139:969-75)G
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SGastroesophageal reflux disease (GERD) is one of the most
common chronic diseases of the gastrointestinal tract, affect-
ing approximately 19 million people in the United States.1
The introduction of laparoscopic fundoplication in 1991
made surgical therapy for GERD a more attractive option
for both patients and referring physicians.2 Unfortunately,
some anti-reflux procedures fail, and recurrent reflux symp-
toms, disabling dysphagia, gas bloat syndrome, anatomic re-
currence of hiatal hernia, or other complications of the
operation develop. Long-term failure rates as high as 25%
have been reported.3,4 In several large series of anti-reflux
operations, 6% to 15% of patients require reoperation.5,6
A repeat anti-reflux procedure may be associated with
a higher expected failure rate than the primary operation,
and occasionally esophageal resection may be the preferred
ultimate treatment option.6-8e Divisions of General Thoracic Surgerya and Biostatistics,b Mayo Clinic,
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The Journal of Thoracic and CaReoperative esophageal surgery can be technically chal-
lenging. Gastric anatomy can be severely distorted by scar-
ring or by herniation of the fundus into the chest.
Furthermore, the stomach may not be suitable for esopha-
geal reconstruction because of damage from prior esophago-
gastric operations. There are little data on whether prior
surgery on the esophagogastric junction has an impact on
the outcomes of subsequent esophageal resection and recon-
struction. We hypothesized that esophagectomy after anti-
reflux surgery was associated with a significantly increased
risk of postoperative complications. The aim of this study is
to test this hypothesis by comparing short- and long-term
outcomes of patients with a fundoplication before esopha-
gectomy with a matched control group who had esophagec-
tomy alone.PATIENTS AND METHODS
Patient Selection and Study Design
All patients who underwent esophageal resection at the Mayo Clinic
between January 1, 1988, and December 31, 2008, were identified from
a prospectively maintained surgical database. Anti-reflux procedures had
been performed at Mayo Clinic Rochester, Minnesota, as well as other
institutions, but all esophageal resections were performed at Mayo Clinic,
Rochester, Minnesota. The techniques used for esophagogastrectomy
have been described by us and included Ivor Lewis, transhiatal, extended
esophagectomy (McKeown), and left thoracoabdominal approach.9-12 The
American Joint Committee for Cancer Staging TNM classification was
used to stage the cancer.13 The medical records were reviewed for demo-
graphic information, presenting symptoms, operative procedures, priorrdiovascular Surgery c Volume 139, Number 4 969
Abbreviations and Acronyms
CI ¼ confidence interval
GERD ¼ gastroesophageal reflux disease
OR ¼ odds ratio
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Ssurgery, pathology, morbidity and mortality, length of hospitalization, and
last follow-up visit or date of death. Operative mortality included all deaths
occurring within 30 days of the operative procedure and those who died later
but during the same hospitalization. Survival data not available in the med-
ical record were obtained from the Social Security Death Index. Follow-up
by chart review and with the primary care physician was performed. The
date of esophagectomy was the starting point in the survival estimation
and the date of death or last follow-up the end point. The Mayo Foundation
Institutional Review Board approved this study with waiver of informed
consent and waiver of the Health Insurance Portability and Accountability
Act.
To assess the impact that previous anti-reflux surgery had on outcomes
after esophagectomy, a control group was created using frequency match-
ing. All patients who had undergone anti-reflux surgery before an esopha-
gectomy in the timeframe of interest were included as cases. Patients
were categorized by gender, age (<60 years, >60 years), surgical era
(1988–1997, 1998–2008), and diagnosis (benign or Barrett’s esophagus
with high-grade dysplasia; cancer), resulting in 8 possible combinations
of the matching criteria. The number of cases having each combination
was identified. The 2233 patients who had undergone esophageal resection
without prior anti-reflux surgery from January 1, 1988, to December 31,
2008, at Mayo Clinic Rochester, Minnesota, comprised the list of potential
controls. Potential control lists were sorted in a random order and reviewed
in sequence until the required number of controls met criteria for inclusion.
Twice as many controls as cases (2:1matching) were selected for each of the
8 combinations.
Gender and age were selected as matching criteria because in a recent
analysis of 162 patients undergoing esophagectomy for locally advanced
esophageal cancer at the Mayo Clinic, we found that age less than 60 years
and female gender were significantly associated with improved survival.14
Matching on diagnosis was also important in creating a well-matched con-
trol group because we also previously showed that the technical difficulties
in patients who undergo esophageal resection for benign disease are greater
than in those who undergo resection for malignancy.7 Symptoms of benign
disease often have been present for years before esophagectomy, and most
of these patients have undergone prior therapeutic procedures. The surgical
era was selected as a matching criteria to account for some of the changes in
surgical technique during the study time period at theMayo Clinic. Whereas
a hand-sewn anastomotic technique was used predominantly in the earlier
surgical era (1988–1997), a linear stapled anastomotic technique was
used more frequently in the later era (1998–2008). In addition, most of
the patients in the earlier era had undergone anti-reflux surgery via an
open laparotomy or thoracotomy approach, whereas a laparoscopic anti-
reflux operation was more common among the patients in the latter era.
Statistical Analysis
Descriptive statistics for categoric variables are reported as frequency and
percentage, and continuous variables are reported as mean (standard
deviation) ormedian (range) as appropriate. For categoric variables, compar-
isons between groups were made using chi-square or Fisher’s exact test as
appropriate. Continuous variables were compared by the Student t test.
All statistical tests were 2-sided. Univariate logistic regression, assessing
covariates of clinical interest and the association of case/control status
with outcomes, was performed to determine factors associated with
increased rates of postoperative complications, anastomotic leak, need for970 The Journal of Thoracic and Cardiovascular Surgreoperation, and death after esophagectomy. Factors analyzed included
age, gender, time period esophagectomy was performed, diagnosis, cancer
stage, history of induction chemoradiation therapy, operative time, surgical
approach used for esophagectomy, type of conduit used for esophageal re-
construction (stomach vs colon/small intestine), location of the anastomosis,
and history of anti-reflux surgery. Univariate analysis of the cases only was
also performed to determine additional factors associatedwith increased risk
of postoperative complications, anastomotic leak, need for reoperation, and
development of anastomotic stricture requiring dilation. In addition to the
factors analyzed for cases and controls, the number of previous anti-reflux
operations, the length of time between anti-reflux operation and esophagec-
tomy, the type of anti-reflux operation performed, the surgical approach used
for the anti-reflux operation, whether a gastroplasty to lengthen the esopha-
gus had been performed, whether the patient had complications after anti-
reflux surgery, and the anastomotic technique used for esophageal recon-
struction were also analyzed. Variables considered in the multiple variable
models were those with a P value of .30 or less in the univariate assessments.
Final models used backward model selection, although for each outcome,
forward selection and a stepwise procedure confirmed the samemodel. Mul-
tiple variable models were not fit for the outcomes of leak, reoperation, and
stricture when assessing only the 80 cases because of the paucity of events
(n¼ 17, 16, and 19, respectively). For the outcome of time to patient death,
univariate Cox proportional hazards models were constructed, assessing
clinically interesting covariates and case/control status. Long-term survival
was estimated using the Kaplan–Meier survival method. SAS v9.1 (SAS
Institute Inc, Cary, NC) was used for all analyses.
Patient Characteristics
During the study time period, 2313 esophageal resections were per-
formed at Mayo Clinic, Rochester, Minnesota, and 80 patients (3.4%) had
undergone previous anti-reflux surgery before esophagectomy (Table 1).
Characteristics of the 80 cases and 160 matched controls are shown in
Table 2.RESULTS
There were 3 operative deaths (3.7%). Cause of death was
respiratory failure in 2 patients and pulmonary artery rupture
from a pulmonary artery catheter balloon in 1 patient. Post-
operative complications occurred in 50 patients (62.5%),
including atrial fibrillation in 19 (23.8%), anastomotic
leak in 17 (21.3%), pneumonia in 16 (20%), wound infec-
tion in 16 (20%), prolonged need for mechanical ventilation
in 11 (13.8%), empyema in 3 (3.8%), and chylothorax in
3 (3.8%). Ten of the patients with anastomotic leak required
reoperation, whereas 7 patients were successfully managed
nonoperatively. The leak rate for a cervical anastomosis
was 38.5% compared with 20.7% in the left side of the chest
and 15.8% in the right side of the chest. Sixteen patients
(20%) required reoperation for complications. Ten patients
underwent reoperation to repair anastomotic leak or to ad-
dress complications of leak, such as empyema or gastrocuta-
neous fistula. For the remaining 6 patients requiring
reoperation, the reason was chylothorax, abdominal wound
dehiscence, reexploration for bleeding from the aorta,
twisted gastric conduit, herniated small bowel, and gastropa-
resis in 1 patient each. The median time interval between
esophagectomy and reoperative procedure was 21 daysery c April 2010
TABLE 1. Characteristics and operative details of 80 patients who
underwent anti-reflux surgery before esophagectomy
Median Range
Interval between anti-reflux
operation and esophagectomy
43.4 mo 1 d to 33.2 y
No. %
Indication for anti-reflux operation
Paraesophageal/hiatal hernia 22 27.5
Gastroesophageal reflux disease 58 72.5
Prior esophageal lengthening procedure
Wedge gastroplasty 13 16.3
Fundoplication only 67 83.7
No. of prior anti-reflux operations
1 52 65
2 24 30
3 3 3.8
4 1 1.2
Total 113
Anti-reflux operations performed
Nissen 84 74%
Belsey 14 12%
Collis–Nissen 6 5%
Toupet 4 4%
Hill 3 3%
Collis–Belsey 2 2%
Total 113 100%
Surgical approach used for anti-reflux operation
Open transabdominal 48 42%
Open transthoracic 40 35%
Laparoscopic 25 22%
Total 113 100%
Complications after anti-reflux surgery
Leak 19 23.4%
Dysphagia 11 13.4%
Stricture 4 5%
Mesh eroded into esophagus 4 5%
Some patients had>1 complication
Anastomotic technique for esophageal reconstruction
Hand-sewn 63 78.7
Mechanical stapler 16 20.0
No anastomosis done 1 1.3
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11.5 days (range, 7–165 days).
The median follow-up was 38.2 months (range, 1 month
to 19.6 years) and was complete in 98.7% of patients. Anas-
tomotic stricture developed in 19 patients (23.8%) requiring
at least 1 dilation. The median number of dilations required
in those with anastomotic stricture was 2 (range, 1–17). At
the time of last follow-up, there were 55 patients alive, 24
patients had died, and 1 patient was lost to follow-up.
Figure 1 shows long-term survival by diagnosis.
There were no statistically significant clinical differences
between the 80 patients who had undergone previous anti-
reflux surgery and the 160 matched control patients who
did not have anti-reflux surgery before esophagectomyThe Journal of Thoracic and Caexcept with respect to the surgical approach used for esoph-
agectomy and the resulting location of the anastomosis
(Table 2). In the patients with prior anti-reflux surgery, the
left thoracoabdominal approach was used more frequently
and the transhiatal and McKeown approaches were used
less frequently than in the control group. As a result, patients
who underwent esophagectomy after an anti-reflux opera-
tion had more anastomoses in the left side of the chest and
fewer in the left side of the neck than in the control group.
This was particularly true for the patients who underwent
esophagectomy for benign disease or failed anti-reflux sur-
gery. A left thoracoabdominal approach was used in
53.7% of these patients compared with only 17.9% of pa-
tients undergoing esophagectomy for malignancy. In con-
trast, the Ivor Lewis approach was used more frequently in
the patients with previous anti-reflux surgery who under-
went esophagectomy for malignancy (64.1% vs 31.7%).
Although the median length of hospitalization was similar
between cases and control groups (11.5 days vs 11.0), the
mean length of hospitalization in the patients with prior
anti-reflux surgery was significantly longer than the patients
with no prior anti-reflux surgery (21.3 24.3 days vs 14.1
9.1 days; P< .001). There were significant differences be-
tween the patients with prior anti-reflux surgery and the
matched control group in rates of postoperative complica-
tions (62.5% vs 36.9%, P < .001), anastomotic leaks
(21.5% vs 10.6%, P ¼ .03), and need for reoperation
(20% vs 8.7%, P ¼ .03).
Univariate analysis of the cases and controls revealed that
increasing age (odds ratio [OR], 1.24; 95% confidence inter-
val [CI], 1.04–1.49; P¼ .02) and a history of anti-reflux sur-
gery before esophagectomy (OR, 2.71; 95% CI, 1.56–4.70;
P< .0004) were the only factors associated with increased
risk of postoperative complications. In a multivariable
model, a transhiatal or McKeown surgical approach (OR,
1.85; 95% CI, 1.02–3.36; P¼ .04) and history of anti-reflux
surgery (OR, 3.19; 95% CI, 1.76–5.78; P¼ .0001) were as-
sociated with increased risk of complications. History of
anti-reflux surgery was also the only factor in univariate
and multivariate analyses associated with increased risk of
anastomotic leak (OR, 2.27; 95% CI, 1.09–4.73; P ¼ .02)
and need for reoperation (OR, 2.29; 95% CI, 1.01–5.19;
P ¼ .04).
In univariate analysis of the cases, an increased number of
prior anti-reflux operations before esophagectomy was asso-
ciated with an increased risk of anastomotic leaks (OR, 2.76;
95% CI, 1.20–6.37; P ¼ .02) and a need for reoperation
(OR, 2.67; 95% CI, 1.13–6.27; P ¼ .02). A cervical anasto-
mosis was associated with an increased risk of anastomotic
leak (OR, 3.27; 95% CI, 0.89–12.09; P ¼ .04). None of the
factors analyzed were associated with an increased risk of
developing anastomotic stricture.
Univariate analysis revealed that increasing age (OR,
1.65; 95% CI, 1.36–1.99, P< .001), age greater than 60rdiovascular Surgery c Volume 139, Number 4 971
TABLE 2. Comparison of variables between patients undergoing esophagectomy who had a previous anti-reflux operation and a frequency-
matched control group with no history of anti-reflux surgery
Previous anti-reflux surgery No previous anti-reflux surgery P value
No. of patients 80 160
Median age, y 63 62 .36
Range 19–92 0.8–95
Gender 1.0
Male 46 (57.5%) 92 (57.5%)
Female 34 (42.5%) 68 (42.5%)
Era esophagectomy performed 1.0
1988–1997 27 (33.7%) 54 (33.7%)
1998–2008 53 (66.3%) 106 (66.3%)
Indication for esophagectomy .98
Benign 41 (51.2%) 81 (50.6%)
Cancer 28 (35%) 58 (36.3%)
HGD 11 (13.8%) 21 (13.1%)
Surgical approach
for esophagectomy
<.001
Ivor Lewis 38 (47.5%) 79 (49.4%)
L TAB 29 (26.2%) 14 (8.7%)
THE 10 (12.5%) 54 (33.8%)
McKeown 3 (3.8%) 13 (8.1%)
Surgical approach
when esophagectomy done
for benign disease
<.001
Ivor Lewis 13 (31.7%) 30 (37.5%)
L TAB 22 (53.7%) 13 (16.2%)
THE 5 (12.2%) 32 (40.0%)
McKeown 1 (2.4%) 5 (6.3%)
Surgical approach
when esophagectomy done
for malignancy
.003
Ivor Lewis 25 (64.1%) 49 (61.2%)
L TAB 7 (17.9%) 1 (1.2%)
THE 5 (12.8%) 22 (27.5%)
McKeown 2 (5.1%) 8 (10%)
Conduit used .23
Stomach 70 (87.5%) 145 (90.6%)
Jejunum 6 (7.5%) 5 (3.1%)
Colon 3 (3.8%) 10 (6.3%)
Jejunostomy tube .22
Yes 35 (43.8%) 80 (50%)
No 45 (56.2%) 80 (50%)
Operative time (min) 360 344.5 .31
Anastomosis location <.001
Right chest 38 (47.5%) 79 (49.4%)
Left chest 29 (36.2%) 14 (8.8%)
Left neck 12 (15%) 67 (41.8%)
Length of stay, d 21.3þ24.3 14.1þ9.1 <.001
Range 7–165 0–56
Postoperative complication 50 (62.5%) 59 (36.9%) <.001
Anastomotic leak 17 (21.5%) 17 (10.6%) .03
Need for reoperation 16 (20%) 14 (8.7%) .03
Operative mortality 3 (3.7%) 1 (0.6%) .07
Follow-up (mo) 38.2 37.9 .22
HGD, High-grade dysplasia; L TAB, left thoracoabdominal; THE, transhiatal esophagectomy.
General Thoracic Surgery Shen et al
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FIGURE 1. Survival after esophagectomy in patients with prior anti-reflux
surgery. Zero time represents the hospital discharge date.
Shen et al General Thoracic Surgeryyears (OR, 2.64; 95% CI, 1.61–4.32, P ¼ .0001), a cancer
diagnosis (OR, 2.00; 95% CI, 1.29–3.10; P ¼ .002), and
more advanced cancer stage (OR, 2.05; 95% CI, 11.56–
2.70; P< .0001) were associated with an increased risk of
death. In multivariate analysis, increasing age (OR, 1.60;
95% CI, 1.32–1.95; P< .0001) and more advanced cancer
stage (OR, 3.90; 95% CI, 2.32–6.52; P< .0001) were the
only independent predictors of death.G
T
SDISCUSSION
Esophagectomy can be a complex operation and histori-
cally has been reported to have significant morbidity and
mortality. In-hospital mortality rates ranging from 7% to
9.8% have been reported based on analyses of large nation-
wide administrative databases, such as the Department of
Veterans Affairs National Surgical Quality Improvement
Program and the Nationwide Inpatient Sample.15,16 Given
the accruing evidence of the beneficial effects of case vol-
ume on esophagectomy outcomes, in low-volume centers,
mortality rates may be even higher.17,18 The most common
complications are respiratory and cardiac.15,16,19 The inci-
dence of pneumonia in large contemporary database series
ranges from 21.4% to 29.9%, with respiratory failure
requiring reintubation occurring in 16.2%.15,19 Atrial fibril-
lation occurs in approximately 12% to 17% of patients.9,20
The incidence of anastomotic leak varies widely. Rates from
0% to 30% have been reported.11,14,21 In contemporary
reports from large database series, anastomotic leak rates
from 8.3% to 11.3% have been reported.22,23
In our study, patients who underwent esophagectomy
after previous anti-reflux surgery experienced higher mor-
bidity when compared with a frequency-matched control
group of comparable patients undergoing esophagectomy
without prior anti-reflux surgery. These complication rates
are also higher than historically reported morbidity occur-
ring in other series. Postoperative complications occurred
in 62.5% of our patients, which is significantly higherThe Journal of Thoracic and Cathan the 36.9% rate in the matched control group of patients
without prior anti-reflux surgery. Patients who underwent
anti-reflux surgery before esophagectomy had a 3.19 in-
creased risk of postoperative complications (P ¼ .0001)
compared with those with no prior surgery. This postopera-
tive complication rate is also higher than the 37% complica-
tion rate that we observed at the Mayo Clinic from 1998 to
2003 in a series of 162 patients who underwent esophago-
gastrectomy after neoadjuvant chemoradiotherapy.14 We
also observed a complication rate of 37.7% in a group of
220 consecutive patients with esophageal cancer who under-
went Ivor Lewis esophagogastrectomy at the Mayo Clinic
between 1992 and 1995.9 The higher morbidity we observed
in this study may be partly due to the pre-esophagectomy
status of many of the patients. Many had experienced gastro-
intestinal discontinuity after failed anti-reflux surgery, with
significant clinical deterioration and sepsis. Forty-four per-
cent of the patients had complications after their anti-reflux
surgery, and 24% had leaks after their anti-reflux operation.
Esophagectomy in this setting can be complicated by a diffi-
cult and lengthy dissection, destroyed tissue planes, and
poor tissue quality.
Occurrence of the early anastomotic complications of
conduit ischemia and anastomotic leak has a significant im-
pact on the outcomes after esophagectomy. They are associ-
ated with an increased morbidity and mortality after
esophagectomy and are risk factors for the development of
the late complication of anastomotic stricture.24,25 Conduit
necrosis is uncommon, with an incidence of approximately
1%.26 It usually occurs secondary to a significant ischemic
insult to the conduit, such as injury to the right gastroepi-
ploic artery. This did not occur in our series, although in
3 patients an intraoperative assessment by the surgeon
judged the stomach to be unsuitable for reconstruction and
colon was used as an alternative conduit. In all 3 patients,
no direct injury to the right gastroepiploic artery occurred;
rather, the appearance of the stomach seemed unfavorable
after a lengthy mobilization of the previous fundoplication
wrap. The stomach was used as the conduit in 69 of the 79
patients (87%) who underwent esophageal reconstruction.
Univariate and multivariate analyses of the cases showed
that there was no difference in rates of postoperative compli-
cations, anastomotic leak, need for reoperation, anastomotic
stricture, or long-term survival in those with a gastric
conduit compared with those who had a colon or small
bowel conduit used for reconstruction.
The anastomotic leak rate of 21.5%observed in this study is
significantly higher than the leak rate of 10.6%observed in the
frequency-matched control group. It is also significantly
higher than the 11.7% anastomotic leak rate we reported in
the 162 patients undergoing esophagogastrectomy for esoph-
ageal cancer after neoadjuvant chemoradiotherapy at the
MayoClinic between 1998 and 2003.14 Patients with a history
of anti-reflux surgery before esophagectomy had a 2.3 timesrdiovascular Surgery c Volume 139, Number 4 973
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those with no prior anti-reflux surgery. Furthermore, we also
found that the leak rate of an anastomosis in the neck was
38.5% comparedwith 21.4% for a left-sided chest anastomo-
sis and a 15.8% leak rate for a right-sided chest anastomosis.
These anastomotic leak rates for intrathoracic anastomoses
are significantly higher than the leak rate we reported in the
761 patients who underwent esophagectomy with an
intrathoracic anastomosis at the Mayo Clinic from 1993 to
2003.24 Patients with a neck anastomosis had a 3.3 times in-
creased risk of anastomotic leak (P¼ .04). The number of pre-
vious anti-reflux surgeries before esophagectomy was also
associated with a significantly increased risk of developing
an anastomotic leak. These findings are consistent with what
other investigators have reported. A recent study of 1133 tran-
shiatal esophagectomies from the University ofMichigan also
found that an increased number of prior esophagogastric
operationswas associatedwith a 2.3 times increased risk of de-
veloping a cervical esophagogastric anastomotic leak.25 We
believe that the major etiologic factor underlying these in-
creased rates of anastomotic failure is that the increased oper-
ative trauma needed to take down scarring around the
previously operated on gastric fundus may place the conduit
at increased risk of ischemia.
The need for reoperation because of early complications
was also significantly higher in the group of patients with
prior anti-reflux compared with the frequency-matched con-
trol group (20% vs 8.7%, P¼ .03). This is partly a function
of the higher anastomotic leak rate in the patients with prior
anti-reflux surgery and the higher rate of postoperative com-
plications in this group of patients. Ten of the patients with
prior anti-reflux surgery who developed anastomotic leaks
required reoperation.
The impact prior anti-reflux surgery has on the outcomes
of subsequent esophagectomy was addressed by Casson and
colleagues.27 Of a consecutive series of 142 patients with
esophageal adenocarcinoma who underwent esophageal
resection, 15 were identified who had undergone prior
anti-reflux surgery. All 15 patients had undergone fundopli-
cation using an ‘‘open’’ surgical approach (11 transabdomi-
nal Nissen and 4 transthoracic Belsey procedures). Gastric
transposition and cervical esophagogastrostomy were
technically feasible in all 15 patients with prior fundoplica-
tion. There was no difference in anastomotic leak rates, mor-
bidity, or subsequent anastomotic stricture rates based on
whether patients had undergone previous fundoplication.
In comparing these results with our findings, there are
several notable differences in the patient characteristics.
First, in our series, the indication for esophageal resection
and reconstruction in the majority of our patients was to treat
complications of prior anti-reflux surgery or failed anti-
reflux surgery. In contrast, all 142 patients in the study by
Casson and colleagues were undergoing esophagectomy to
treat esophageal adenocarcinoma. In addition, in our study974 The Journal of Thoracic and Cardiovascular Surg28 of the patients (35%) had undergone at least 2 prior
anti-reflux procedures before the esophagectomy. None of
the patients reported by Casson and colleagues had more
than 1 prior anti-reflux operation. One of the important
findings in our study is that an increased number of prior
anti-reflux operations was associated with increased risk of
anastomotic leak and need for reoperation. Finally, 13 of
the patients in our study at the time of anti-reflux surgery
had evidence of a shortened esophagus and in turn had
esophageal lengthening by gastroplasty. None of the patients
in Casson and colleagues’ study had undergone a prior
gastroplasty.Limitations
The primary limitation of this study is that it is a retrospec-
tive analysis of a group of patients treated surgically by 6 dif-
ferent surgeons over a 21-year period at a single institution.
In addition, the patients were a heterogeneous group. At the
time of esophagectomy, some patients had undergone mul-
tiple failed previous operations with significant clinical dete-
rioration and sepsis. These patients would be expected to be
at greater risk for postoperative complications than those
patients undergoing esophagectomy in an elective setting.CONCLUSIONS
Esophagectomy after prior anti-reflux surgery is chal-
lenging. The stomach is usually a suitable conduit for
esophageal replacement in these circumstances. Patients
with a history of anti-reflux surgery who undergo esopha-
gectomy are at significantly increased risk for postoperative
complications, including anastomotic leak, and need for re-
operation compared with patients who have not undergone
prior anti-reflux surgery. In light of the increased risk of cer-
vical anastomotic leaks, intrathoracic anastomosis may be
preferable.
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